Deutsche Bank’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Deutsche Bank’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,140	Closed	-$82K	–	6342
2014 Q4	$82K	Buy	17,140 +2,998	+21%	+$13.4K	﹤0.01%	4845
2014 Q3	$58K	Sell	14,142 -6,761	-32%	-$31.5K	﹤0.01%	4786
2014 Q2	$123K	Buy	20,903 +1,975	+10%	+$11.2K	﹤0.01%	4436
2014 Q1	$120K	Sell	18,928 -33,572	-64%	-$303K	﹤0.01%	4150
2013 Q4	$499K	Buy	+52,500	New	+$410K	﹤0.01%	3118

Other funds holding TLOG

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank's TLOG Position: Q1 2015 in Review

Deutsche Bank sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2015, closing a stake of 17,140 shares — an estimated $82K sold.

Deutsche Bank first reported a position in TLOG in Q4 2013 and held it in 5 quarters. The position peaked at $499K in Q4 2013. 31 funds tracked by Wall St. Rank hold TLOG as of Q1 2015.

Deutsche Bank reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 17,140 TetraLogic Pharmaceuticals Corporation shares in Q1 2015, an estimated $82K.
Deutsche Bank first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 5 quarters.
Deutsche Bank's TetraLogic Pharmaceuticals Corporation position peaked at $499K in Q4 2013.
31 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.